Drug Shortage Report for ERWINASE
Report ID | 57204 |
Drug Identification Number | 02237815 |
Brand name | ERWINASE |
Common or Proper name | L-asparaginase |
Company Name | JAZZ PHARMACEUTICALS FRANCE SAS |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ASPARAGINASE |
Strength(s) | 10000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 3 mL vials (20 vials per carton) |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-07-30 |
Estimated end date | 2018-08-10 |
Actual end date | 2018-08-10 |
Shortage status | Resolved |
Updated date | 2018-08-13 |
Company comments | Unanticipated delay in the scheduled release of the next batch of product |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 84 QUAI CHARLES DE GAULLE CITY ONE LYON, AUVERGNE-RHONE-ALPES FRANCE 69006 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-08-13 | French | Compare |
v3 | 2018-08-13 | English | Compare |
v2 | 2018-08-01 | French | Compare |
v1 | 2018-08-01 | English | Compare |
Showing 1 to 4 of 4